Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01200251 · ClinicalTrials.gov registry record · Phase 3
Study of Bimatoprost Gel on Eyelash Growth
A Phase 3 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT01200251 is a Phase 3 study that has completed, run by Duke University. The registered enrollment target is 20 participants.
The verdict
NCT01200251, a Phase 3 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
Interventions
- DRUG Bimatoprost eyelash gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01200251
The ClinicalTrials.gov registry entry for NCT01200251 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bimatoprost eyelash gel is the first listed.
NCT01200251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01200251 about?
NCT01200251 is a clinical study titled "Study of Bimatoprost Gel on Eyelash Growth". A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obta...
What is the current status of trial NCT01200251?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2007-02. Estimated completion is 2008-12.
What interventions are being tested in trial NCT01200251?
The interventions under investigation include: Bimatoprost eyelash gel (DRUG).
Who is sponsoring clinical trial NCT01200251?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.